S&P 500   3,901.36 (+0.01%)
DOW   31,261.90 (+0.03%)
QQQ   288.46 (-0.39%)
AAPL   137.39 (+0.03%)
MSFT   252.66 (-0.19%)
FB   193.54 (+1.18%)
GOOGL   2,178.18 (-1.34%)
AMZN   2,154.20 (+0.36%)
TSLA   662.46 (-6.62%)
NVDA   167.39 (-2.25%)
BABA   86.80 (-1.01%)
NIO   16.50 (-0.96%)
AMD   93.61 (-3.17%)
CGC   5.52 (-5.96%)
MU   68.92 (-0.69%)
T   20.43 (+1.09%)
GE   75.30 (-0.58%)
F   12.45 (-3.11%)
DIS   102.25 (-0.86%)
AMC   12.03 (-8.03%)
PFE   52.47 (+3.59%)
PYPL   80.78 (-0.62%)
NFLX   186.35 (+1.56%)
S&P 500   3,901.36 (+0.01%)
DOW   31,261.90 (+0.03%)
QQQ   288.46 (-0.39%)
AAPL   137.39 (+0.03%)
MSFT   252.66 (-0.19%)
FB   193.54 (+1.18%)
GOOGL   2,178.18 (-1.34%)
AMZN   2,154.20 (+0.36%)
TSLA   662.46 (-6.62%)
NVDA   167.39 (-2.25%)
BABA   86.80 (-1.01%)
NIO   16.50 (-0.96%)
AMD   93.61 (-3.17%)
CGC   5.52 (-5.96%)
MU   68.92 (-0.69%)
T   20.43 (+1.09%)
GE   75.30 (-0.58%)
F   12.45 (-3.11%)
DIS   102.25 (-0.86%)
AMC   12.03 (-8.03%)
PFE   52.47 (+3.59%)
PYPL   80.78 (-0.62%)
NFLX   186.35 (+1.56%)
S&P 500   3,901.36 (+0.01%)
DOW   31,261.90 (+0.03%)
QQQ   288.46 (-0.39%)
AAPL   137.39 (+0.03%)
MSFT   252.66 (-0.19%)
FB   193.54 (+1.18%)
GOOGL   2,178.18 (-1.34%)
AMZN   2,154.20 (+0.36%)
TSLA   662.46 (-6.62%)
NVDA   167.39 (-2.25%)
BABA   86.80 (-1.01%)
NIO   16.50 (-0.96%)
AMD   93.61 (-3.17%)
CGC   5.52 (-5.96%)
MU   68.92 (-0.69%)
T   20.43 (+1.09%)
GE   75.30 (-0.58%)
F   12.45 (-3.11%)
DIS   102.25 (-0.86%)
AMC   12.03 (-8.03%)
PFE   52.47 (+3.59%)
PYPL   80.78 (-0.62%)
NFLX   186.35 (+1.56%)
S&P 500   3,901.36 (+0.01%)
DOW   31,261.90 (+0.03%)
QQQ   288.46 (-0.39%)
AAPL   137.39 (+0.03%)
MSFT   252.66 (-0.19%)
FB   193.54 (+1.18%)
GOOGL   2,178.18 (-1.34%)
AMZN   2,154.20 (+0.36%)
TSLA   662.46 (-6.62%)
NVDA   167.39 (-2.25%)
BABA   86.80 (-1.01%)
NIO   16.50 (-0.96%)
AMD   93.61 (-3.17%)
CGC   5.52 (-5.96%)
MU   68.92 (-0.69%)
T   20.43 (+1.09%)
GE   75.30 (-0.58%)
F   12.45 (-3.11%)
DIS   102.25 (-0.86%)
AMC   12.03 (-8.03%)
PFE   52.47 (+3.59%)
PYPL   80.78 (-0.62%)
NFLX   186.35 (+1.56%)
ETR:DRW3

Drägerwerk AG & Co. KGaA (DRW3) Stock Forecast, Price & News

€48.40
-0.30 (-0.62%)
(As of 05/19/2022 12:00 AM ET)
Add
Compare
Today's Range
€48.05
€48.65
50-Day Range
€46.25
€54.60
52-Week Range
€45.45
€82.70
Volume
35,547 shs
Average Volume
33,804 shs
Market Capitalization
$416.24 million
P/E Ratio
6.76
Dividend Yield
0.40%
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive DRW3 News and Ratings via Email

Sign-up to receive the latest news and ratings for Drägerwerk AG & Co. KGaA and its competitors with MarketBeat's FREE daily newsletter.

Drägerwerk AG & Co. KGaA logo

About Drägerwerk AG & Co. KGaA

Drägerwerk AG & Co. KGaA operates as a medical and safety technology company in Europe, the Americas, Africa, Asia, and Australia. The company develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency care, perioperative care, critical care, and perinatal care. It also develops, produces, and markets products, system solutions, and services for personal protection, gas detection technology, and integrated hazard management to customers in industry and mining sectors, as well as public sectors, such as fire departments, police, and disaster protection. The company's products portfolio includes anesthesia devices and ventilators, thermoregulation equipment, consumables and accessories, supply units, lights, gas management systems, patient monitoring, software applications, system products, and other services. Its product portfolio also comprises stationary and mobile gas detection systems, personal protective equipment, and alcohol and drug testing devices. In addition, the company offers various training and services, as well as fire training facilities for firefighters. Drägerwerk AG & Co. KGaA was founded in 1889 and is headquartered in Lübeck, Germany.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Medical Devices
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
14,910
Year Founded
N/A

Sales & Book Value

Annual Sales
$3.19 billion
Cash Flow
€30.50 per share
Book Value
€67.16 per share

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
$416.24 million
Optionable
Not Optionable

MarketRank

Overall MarketRank

1.83 out of 5 stars

Analyst Opinion: 3.0Community Rank: 3.5Dividend Strength: 0.8Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -













Drägerwerk AG & Co. KGaA (ETR:DRW3) Frequently Asked Questions

Is Drägerwerk AG & Co. KGaA a buy right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Drägerwerk AG & Co. KGaA in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" Drägerwerk AG & Co. KGaA stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in DRW3, but not buy additional shares or sell existing shares.
View analyst ratings for Drägerwerk AG & Co. KGaA
or view top-rated stocks.

Is Drägerwerk AG & Co. KGaA a good dividend stock?

Drägerwerk AG & Co. KGaA pays an annual dividend of €0.19 per share and currently has a dividend yield of 0.40%. The dividend payout ratio of Drägerwerk AG & Co. KGaA is 2.65%. This payout ratio is at a healthy, sustainable level, below 75%.

What price target have analysts set for DRW3?

1 brokerages have issued 12 month price targets for Drägerwerk AG & Co. KGaA's shares. Their forecasts range from €52.70 to €96.50. On average, they anticipate Drägerwerk AG & Co. KGaA's stock price to reach €69.05 in the next twelve months. This suggests a possible upside of 42.7% from the stock's current price.
View analysts' price targets for Drägerwerk AG & Co. KGaA
or view top-rated stocks among Wall Street analysts.

Who are Drägerwerk AG & Co. KGaA's key executives?
Drägerwerk AG & Co. KGaA's management team includes the following people:
  • Mr. Stefan A. Drager B.A., Chairman of the Exec. Board - Drägerwerk Verwaltungs AG (Age 59, Pay $2.06M)
  • Mr. Gert-Hartwig Lescow, CFO, Exec. Board Member for IT & Vice Chairman of Exec. Board - Drägerwerk Verwaltungs AG (Age 55, Pay $1.35M)
  • Mr. Anton Schrofner, Exec. Board Member for Medical Division - Drägerwerk Verwaltungs AG (Age 59, Pay $1.14M)
  • Mr. Rainer Klug, Exec. Board Member for Safety Division - Drägerwerk Verwaltungs AG (Age 54, Pay $1.07M)
  • Dr. Reiner Piske, Exec. Board Member for Sales & HR - Drägerwerk Verwaltungs AG (Age 52, Pay $1.15M)
  • Stephan Kruse, Pres Bus. Unit Therapy, Medical Div. & Member of Supervisory Board (Age 52, Pay $40k)
  • Thomas Fischler, Head of Treasury & Investor Relations
  • Mr. Welf Böttcher, Head of Corp. Communications
What other stocks do shareholders of Drägerwerk AG & Co. KGaA own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Drägerwerk AG & Co. KGaA investors own include ServiceNow (NOW), NVIDIA (NVDA), Skyworks Solutions (SWKS), Broadcom (AVGO), eBay (EBAY), Enterprise Products Partners (EPD), Tesla (TSLA), Verizon Communications (VZ), Advance Auto Parts (AAP) and Advanced Micro Devices (AMD).

What is Drägerwerk AG & Co. KGaA's stock symbol?

Drägerwerk AG & Co. KGaA trades on the ETR under the ticker symbol "DRW3."

What is Drägerwerk AG & Co. KGaA's stock price today?

One share of DRW3 stock can currently be purchased for approximately €48.40.

How much money does Drägerwerk AG & Co. KGaA make?

Drägerwerk AG & Co. KGaA has a market capitalization of $416.24 million and generates $3.19 billion in revenue each year.

How many employees does Drägerwerk AG & Co. KGaA have?

Drägerwerk AG & Co. KGaA employs 14,910 workers across the globe.

What is Drägerwerk AG & Co. KGaA's official website?

The official website for Drägerwerk AG & Co. KGaA is www.draeger.com.

How can I contact Drägerwerk AG & Co. KGaA?

Drägerwerk AG & Co. KGaA's mailing address is Moislinger Allee 53-55, LUEBECK, 23558, Germany. The company can be reached via phone at +49-451-8820.

This page was last updated on 5/20/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.